A national research database led by the Clinical Trials Unit at WMS has revealed stark figures for cardiac arrests in England for 2022, with just 1 in 12 people surviving 30 days after an out-of-hospital cardiac arrest.

A new diagnostic device could help those who experience sleep apnoea get a quicker diagnosis and an improved quality of life, thanks to a trial being led by Warwick Medical School researchers.

Dr Katherina Brinkert interviewed in BBC Science Focus magazine on solar power in space. tinyurl.com/3kdnrs3v

Aylesford Sixth Form Science students welcomed to complete practical exams and gain hands-on experience in our labs following classroom closures. More at tinyurl.com/mr4d4hpr

Thousands of people with type 1 diabetes could be offered wearable technology to help them manage their condition thanks to guidance based on research conducted by WMS.

The world’s largest review on opioid medicines for cancer pain, which included WMS researchers, has found it is unclear whether some commonly used opioid medicines are better than a placebo and suggests that non-opioid medicines, including aspirin, may be as effective as opioids.

Mammography for some breast cancer survivors could be reduced, according to research led by Warwick Medical School’s Clinical Trials Unit.

A team at Warwick Medical School’s Clinical Trials Unit have won a prestigious award at the Clinical Research Network Awards, alongside colleagues from the West Midlands Ambulance Service.

Dr Mark Greenhalgh, has secured a substantial grant from the EPSRC to establish an international collaboration for his pioneering research in catalysis and molecular interactions.

Associate Professor Meera Unnikrishnan from the Division of Biomedical Sciences has been awarded a Wellcome Discovery Award from the Wellcome Trust to the value of £2,225,509. Her project, ‘Dissecting Clostridioides difficile-host-commensal interactions at the gut interface’, will take place over eight years.